Delivery Order SPE2DB20D2104-SPE2DB24FS62G
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.59 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, with a performance period ending on May 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,026.84, is for the delivery of EUCRISA 2% Ointment 60GM, a prescription medication. The contract has a performance period through June 4, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.67, is for the delivery of EUCRISA 2% ointment 60GM. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award (SPE2DB20D3505|SPE2DB24FT5B9) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,939.73 firm fixed-price delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eucrisa 2% ointment in 60-gram tubes. The $9,606.75 firm-fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora to provide a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order valued at $1,913.65 for the pharmaceutical product EUCRISA 2% Ointment 60GM. The contract has an ultimate completion date of September 7, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $1,299.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product EUCRISA 2% Ointment 60GM. It has an ultimate completion date of May 7, 2024 and a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of EUCRISA 2% ointment, a specialty pharmaceutical product, with a ceiling value of $1,554.51 and an ultimate completion date of January 14, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,913.99, is for the delivery of EUCRISA 2% Ointment 60GM, a pharmaceutical product. The contract has an ultimate completion date of September 20, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This contract award, with ID SPE2DB20D1004|SPE2DB22FF0C3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,218.34 firm fixed-price delivery order is for the supply of the pharmaceutical product EUCRISA 2% Ointment 60GM. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS62GDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,458.23 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, to support military healthcare programs. The award is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 2/16/24 |